Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment

Documenti analoghi

• ITGB1 Regulates Triple‐Negative Breast Cancer Development by Modulating the Tumor Microenvironment
  di: Nuozi Song, et al.
  Pubblicazione: (2026)
• Identifying Therapeutic Targets for Triple-Negative Breast Cancer using a Novel Mathematical Model of the Tumor Microenvironment
  di: Adams, Kyle, et al.
  Pubblicazione: (2026)
• Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
  di: Mengyun Wan, et al.
  Pubblicazione: (2025)
• Nanointegrative Glycoengineering‐Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self‐Amplifiable Immunotherapy for Systemic Tumor Rejection
  di: Youbo Zhao, et al.
  Pubblicazione: (2024)
• Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy
  di: Yumeng Xing, et al.
  Pubblicazione: (2024)